Vimarsana
Biggest News Aggregation in the World

Page 25 - Pharma Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Research Today - Breaking & Trending Today

Relief Therapeutics Announces Promising Initial Stability Data on a New Formulation of RLF-100® (Avi - Vimarsana News

Relief Therapeutics Announces Promising Initial Stability Data on a New Formulation of RLF-100® (Avi

Relief Therapeutics Holding SA / Key word(s): Research Update03-Aug-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics Announces Promising Initial Stability Data on a New Formulation of RLF-100® (Avipt...

Adhoc: Relief Therapeutics Holding SA: Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease - Vimarsana News

Adhoc: Relief Therapeutics Holding SA: Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease

Relief Therapeutics Holding SA / Key word(s): Regulatory Admission Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease 28-Jul-2022

Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease - Vimarsana News

Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease

28.07.2022 Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease | Relief Therapeutics Holding SA | News | Nachricht | Mitteilung

Source: dgap.de
Adhoc: Relief Therapeutics Holding SA: Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Review of NDA Resubmission for ACER-001 for Treatment of UCDs - Vimarsana News

Adhoc: Relief Therapeutics Holding SA: Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Review of NDA Resubmission for ACER-001 for Treatment of UCDs

Relief Therapeutics Holding SA / Key word(s): Regulatory Admission Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Review of NDA Resubmission for ACER-001 for Treatment of UCDs

Relief Therapeutics Announces Effectiveness of Registration Statement on Form 20-F - Vimarsana News

Relief Therapeutics Announces Effectiveness of Registration Statement on Form 20-F

Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Announces Effectiveness of Registration Statement on Form 20-F 21-Jul-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announceme...